Evidence map›Paper›PMID 38868402›Full record

ArticlePCN reports : psychiatry and clinical neurosciences2023

A fatal case of fulminant neuroleptic malignant syndrome: A case report.

Hitomi Komoriya, Konoka Nomura, Toshinori Shirata, Tadahiro Kobayashi, Masaki Nakane, Keisuke Noto, Ryota Kobayashi, Akihito Suzuki

Abstract readCase Reports
In one paragraph

Article in PCN reports : psychiatry and clinical neurosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. A fatal case of fulminant neuroleptic malignant syndrome: A case report.PCN reports : psychiatry and clinical neurosciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hitomi KomoriyaDepartment of Psychiatry Yamagata University School of Medicine Yamagata Japan.
Konoka NomuraDepartment of Psychiatry Yamagata University School of Medicine Yamagata Japan.
Toshinori ShirataDepartment of Psychiatry Yamagata University School of Medicine Yamagata Japan.ORCID 0000-0002-9118-0363
Tadahiro KobayashiDepartment of Emergency and Critical Care Medicine Yamagata University School of Medicine Yamagata Japan.
Masaki NakaneDepartment of Emergency and Critical Care Medicine Yamagata University School of Medicine Yamagata Japan.
Keisuke NotoDepartment of Psychiatry Yamagata University School of Medicine Yamagata Japan.
Ryota KobayashiDepartment of Psychiatry Yamagata University School of Medicine Yamagata Japan.
Akihito SuzukiDepartment of Psychiatry Yamagata University School of Medicine Yamagata Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Neuroleptic malignant syndrome (NMS), a rare but potentially life-threatening adverse reaction to treatment with antipsychotic drugs, is characterized by hyperthermia, muscle rigidity, impaired consciousness, and autonomic disturbances. Some reports have described rapidly progressing cases of NMS resulting in death within several days. This report describes a clinical course of fatal and fulminant NMS in a patient with schizoaffective disorder. Case Presentation: A 67-year-old man had long been in a stable condition under antipsychotic pharmacotherapy. At 3 days before admission to our hospital, he complained of diarrhea, fatigue, and reduced appetite. On admission to our hospital, he showed fever, mild muscle rigidity at the four extremities, elevated heart rate, hypertension, excessive diaphoresis, and decreased percutaneous oxygen saturation (SpO Conclusion: The present case suggests that severe hyperthermia and severe autonomic disturbances at the early stage of the onset might be signs of fatal and fulminant NMS. It may be recommended that clinicians consider electro-convulsive therapy when treating fulminant NMS with these symptoms.

Indexed as

fatal and fulminant caseneuroleptic malignant syndromeschizoaffective disordersevere autonomic disturbancessevere hyperthermia

Identifiers

PMID38868402
PMCPMC11114324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.